Cisplatin enhances cell stiffness and decreases invasiveness rate in prostate cancer cells by actin accumulation

Sci Rep. 2019 Feb 7;9(1):1660. doi: 10.1038/s41598-018-38199-7.


We focused on the biomechanical and morphological characteristics of prostate cancer cells and their changes resulting from the effect of docetaxel, cisplatin, and long-term zinc supplementation. Cell population surviving the treatment was characterized as follows: cell stiffness was assessed by atomic force microscopy, cell motility and invasion capacity were determined by colony forming assay, wound healing assay, coherence-controlled holographic microscopy, and real-time cell analysis. Cells of metastatic origin exhibited lower height than cells derived from the primary tumour. Cell dry mass and CAV1 gene expression followed similar trends as cell stiffness. Docetaxel- and cisplatin-surviving cells had higher stiffness, and decreased motility and invasive potential as compared to non-treated cells. This effect was not observed in zinc(II)-treated cells. We presume that cell stiffness changes may represent an important overlooked effect of cisplatin-based anti-cancer drugs. Atomic force microscopy and confocal microscopy data images used in our study are available for download in the Zenodo repository ( , Digital Object Identifiers:10.5281/zenodo.1494935).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism*
  • Antineoplastic Agents / pharmacology*
  • Cell Proliferation*
  • Cisplatin / pharmacology*
  • Humans
  • Male
  • Mechanotransduction, Cellular*
  • Neoplasm Invasiveness
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Tumor Cells, Cultured
  • Wound Healing


  • Actins
  • Antineoplastic Agents
  • Cisplatin